Summary
ProMetic Life Sciences Inc. (ProMetic) is a biopharmaceutical company that focuses on bioseparations, plasma-derived therapeutics and small-molecule drug development. The company operates through its segments such as protein technologies and therapeutics. Its protein technologies include bioseparation technologies and plasma protein purification system. ProMetic’s Therapeutics includes PBI-1402, an orally active low molecular weight synthetic drug candidate for the treatment of chemotherapy induced anemia. Its bioseparation products include antibody and antibody fragments, general purification, glycoprotein separation, and endotoxin, among others. The company owns and operates researdh and development facilities in the UK, the US and Canada as well as manufacturing facilities in the UK and business development activities in the US, Europe and Asia. ProMetic is headquartered in Laval, Quebec, Canada.
ProMetic Life Sciences Inc. (PLI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
ProMetic Life Sciences Acquires Plasma Collection Center in Canada from Emergent BioSolutions 13
Partnerships 14
ProMetic Life Sciences Enters into Agreement with ProThera Biologics 14
ProMetic BioSciences Enters Into Co-Development Agreement With Pharma Company 15
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 16
ProMetic Life Sciences Enters Into Joint Venture Agreement With NantPharma 18
ProMetic Life Sciences Enters Into Co-Development Agreement With Hematech Biotherapeutics 19
ProMetic Enters Into Strategic Agreement With Allist Pharma For PBI-1402 And PBI-4419 21
Novozymes Enters Into Co-Marketing Agreement With ProMetic Life Sciences 23
ProMetic Life Sciences Enters Into Co-Development Agreement With Abraxis BioScience 24
Licensing Agreements 25
ProMetic Life Sciences Enters into Licensing Agreement with Omnio 25
ProMetic Life Sciences Enters into Licensing Agreement with Generium 26
ProMetic Life Sciences Enters Into Licensing Agreement For Its Affinity Resin Technology 27
ProMetic Life Sciences Enters Into Licensing Agreement With Shenzhen Hepalink Pharma 28
ProMetic Life Sciences Expands Licensing Agreement With Wuhan Institute 29
ProMetic Enters Into An Agreement With Celgene 30
ProMetic Life Sciences Terminates Licensing Agreement With Tecpar 31
Equity Offering 32
ProMetic Life Sciences to Raise USD47.8 Million in Public Offering of Shares 32
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment Option for USD7.5 Million Bought Deal Public Offering of Shares 34
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment of Public Offering of Shares 36
ProMetic Life Sciences Completes Private Placement Of Shares For US$23 Million 38
ProMetic Life Sciences Finalizes Private Placement Of Shares For US$10 Million 40
ProMetic Life Sciences Completes Private Placement Of Shares For US$1 Million 41
ProMetic Life Sciences Completes Private Placement Of US$3 Million 42
Debt Offering 44
ProMetic Life Sciences Raises USD30 Million in Private Placement of 8% Notes Due 2022 44
Acquisition 45
ProMetic Life Sciences Acquires Additional Stake In NantPro BioSciences 45
ProMetic Life Sciences Inc. - Key Competitors 46
Key Employees 47
Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
List of Tables
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
ProMetic Life Sciences Inc., Deals By Therapy Area, 2010 to YTD 2016 9
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
ProMetic Life Sciences Acquires Plasma Collection Center in Canada from Emergent BioSolutions 13
ProMetic Life Sciences Enters into Agreement with ProThera Biologics 14
ProMetic BioSciences Enters Into Co-Development Agreement With Pharma Company 15
ProMetic Life Sciences Enters Into Co-Marketing Agreement With Sartorius Stedim Biotech 16
ProMetic Life Sciences Enters Into Joint Venture Agreement With NantPharma 18
ProMetic Life Sciences Enters Into Co-Development Agreement With Hematech Biotherapeutics 19
ProMetic Enters Into Strategic Agreement With Allist Pharma For PBI-1402 And PBI-4419 21
Novozymes Enters Into Co-Marketing Agreement With ProMetic Life Sciences 23
ProMetic Life Sciences Enters Into Co-Development Agreement With Abraxis BioScience 24
ProMetic Life Sciences Enters into Licensing Agreement with Omnio 25
ProMetic Life Sciences Enters into Licensing Agreement with Generium 26
ProMetic Life Sciences Enters Into Licensing Agreement For Its Affinity Resin Technology 27
ProMetic Life Sciences Enters Into Licensing Agreement With Shenzhen Hepalink Pharma 28
ProMetic Life Sciences Expands Licensing Agreement With Wuhan Institute 29
ProMetic Enters Into An Agreement With Celgene 30
ProMetic Life Sciences Terminates Licensing Agreement With Tecpar 31
ProMetic Life Sciences to Raise USD47.8 Million in Public Offering of Shares 32
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment Option for USD7.5 Million Bought Deal Public Offering of Shares 34
ProMetic Life Sciences Announces Underwriters Exercise of Over-Allotment of Public Offering of Shares 36
ProMetic Life Sciences Completes Private Placement Of Shares For US$23 Million 38
ProMetic Life Sciences Finalizes Private Placement Of Shares For US$10 Million 40
ProMetic Life Sciences Completes Private Placement Of Shares For US$1 Million 41
ProMetic Life Sciences Completes Private Placement Of US$3 Million 42
ProMetic Life Sciences Raises USD30 Million in Private Placement of 8% Notes Due 2022 44
ProMetic Life Sciences Acquires Additional Stake In NantPro BioSciences 45
ProMetic Life Sciences Inc., Key Competitors 46
ProMetic Life Sciences Inc., Key Employees 47
ProMetic Life Sciences Inc., Other Locations 48
ProMetic Life Sciences Inc., Subsidiaries 49
List of Figures
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 7
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8
ProMetic Life Sciences Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9
